- Home
- VATE vs MAIA Comparison
VATE vs MAIA Comparison
Compare VATE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- MAIA
- Stock Information
- Founded
- VATE 1994
- MAIA 2018
- Country
- VATE United States
- MAIA United States
- Employees
- VATE 4024
- MAIA N/A
- Industry
- VATE Metal Fabrications
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- MAIA Health Care
- Exchange
- VATE Nasdaq
- MAIA Nasdaq
- Market Cap
- VATE 82.6M
- MAIA 62.4M
- IPO Year
- VATE 1996
- MAIA 2022
- Fundamental
- Price
- VATE $6.10
- MAIA $2.82
- Analyst Decision
- VATE
- MAIA
- Analyst Count
- VATE 0
- MAIA 0
- Target Price
- VATE N/A
- MAIA N/A
- AVG Volume (30 Days)
- VATE 50.3K
- MAIA 60.0K
- Earning Date
- VATE 11-06-2024
- MAIA 11-05-2024
- Dividend Yield
- VATE N/A
- MAIA N/A
- EPS Growth
- VATE N/A
- MAIA N/A
- EPS
- VATE N/A
- MAIA N/A
- Revenue
- VATE $1,364,600,000.00
- MAIA N/A
- Revenue This Year
- VATE N/A
- MAIA N/A
- Revenue Next Year
- VATE N/A
- MAIA N/A
- P/E Ratio
- VATE N/A
- MAIA N/A
- Revenue Growth
- VATE N/A
- MAIA N/A
- 52 Week Low
- VATE $3.25
- MAIA $0.82
- 52 Week High
- VATE $14.60
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- VATE 71.67
- MAIA 50.98
- Support Level
- VATE $6.18
- MAIA $2.36
- Resistance Level
- VATE $6.49
- MAIA $2.72
- Average True Range (ATR)
- VATE 0.43
- MAIA 0.22
- MACD
- VATE 0.05
- MAIA 0.02
- Stochastic Oscillator
- VATE 86.72
- MAIA 72.28
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.